2010 HCPCS G9077
Oncology; disease status; prostate cancer, limited to adenocarcinoma as predominant cell type; t1-t2c and gleason 2-7 and psa < or equal to 20 at diagnosis with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)

  • This is the 2010 version of HCPCS G9077 - please refer to the 2016 HCPCS code set for the latest version.
  • Added on Sunday, January 01, 2006
  • Status changed on Monday, January 01, 2007 to: No maintenance for this code
  • BETOS Classification: Oncology > Other
  • Medicare coverage status: Carrier judgment

  G9076    G9078